Acetaminophen has limited antipyretic activity in critically ill patients

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 363.e1-363.e7

  Greenberg, Rachel S ^a,b   Chen, Hegang ^a,b   Hasday, Jeffrey D ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

Acetaminophen; Antipyretic; Critically ill; Fever; Systemic inflammatory response syndrome

Indexed keywords

PARACETAMOL;

ADULT; ANTIPYRETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; COOLING; CRITICALLY ILL PATIENT; DIGESTIVE FUNCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; THERMOREGULATION;

EID: 77953291376     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.07.005     Document Type: Article

References (32)

1. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. J Am Med Assoc 1995, 273:117-123.
2. Hasday J.D., Fairchild K.D., Shanholtz C. The role of fever in the infected host. Microbes Infect 2000, 2:1-14.
3. Hajat C., Hajat S., Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000, 31:410-414.
4. Jiang J.Y., Gao G.Y., WP L., Yu M.K., Zhu C. Early indicators of prognosis in 846 cases of severe traumatic brain injury. J Neurotrauma 2002, 19:869-874.
5. Bernard G.R., Wheeler A.P., Russell J.A., Schein R., Summer W.R., Steinberg K.P., et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 1997, 336(13):912-918. [see comments].
6. Schulman C.I., Namias N., Doherty J., Manning R.J., Li P., Alhaddad A., et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surg Infect (Larchmt) 2005, 6(4):369-375.
7. Hasday J., Garrison A., Singh I., Standiford T., Ellis G., Rao S., et al. Febrile-range hyperthermia augments pulmonary neutrophil recruitment and amplifies pulmonary oxygen toxicity. Am J Pathol 2003, 200(5-2017):162.
8. Hasday J.D., Bannerman D., Sakarya S., Cross A.S., Singh I.S., Howard D., et al. Exposure to febrile temperature modifies endothelial cell response to tumor necrosis factor-α. J Appl Physiol 2001, 90:90-98.
9. Rice P., Martin E., He J.R., Frank M., DeTolla L., Hester L., et al. Febrile-range hyperthermia augments neutrophil accumulation and enhances lung injury in experimental gram-negative bacterial pneumonia. J Immunol 2005, 174:3676-3685.
10. Sharma H.S., Duncan J.A., Johanson C.E. Whole-body hyperthermia in the rat disrupts the blood-cerebrospinal fluid barrier and induces brain edema. Acta Neurochir Suppl 2006, 96:426-431.
11. Sharma H.S., Johanson C.E. Blood-cerebrospinal fluid barrier in hyperthermia. Prog Brain Res 2007, 162:459-478.
12. Manthous C., Hall J., Olson D., Singh M., Chatila W., Pohlman A., et al. Effect of cooling on oxygen consumption in febrile critically ill patients. Am J Respir Crit Care Med 1995, 151:10-14.
13. Isaacs S.N., Axelrod P.I., Lorber B. Antipyretic orders in a university hospital. Am J Med 1990, 88:31-35.
14. Henker R., Rogers S., Kramer D.J., Kelso L., Kerr M., Sereika S. Comparison of fever treatments in the critically ill: a pilot stud. Am J Crit Care 2001, 10:276-280.
15. Mackenzie I., Forrest K., Thompson F., Marsh R. Effects of acetaminophen administration to patients in intensive care. Intensive Care Med 2000, 26:1408.
16. Gozzoli V., Treggiari M.M., Kleger G.R., Roux-Lombard P., Fathi M., Pichard C., et al. Randomized trial of the effect of antipyresis by metamizol, propacetamol or external cooling on metabolism, hemodynamics and inflammatory response. Intensive Care Med 2004, 30:401-407.
17. Poblete B., Romand J.A., Pichard C., Konig P., Suter P.M. Metabolic effects of i.v. propacetamol, metamizol or external cooling in critically ill febrile sedated patients. Br J Anethesia 1997, 78:123-127.
18. McCulloch C.E., Searle S.R. Generalized, linear, and mixed models 2001, Wiley & Sons, New York City.
19. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
20. Gross P.A., Barrett T.L., Dellinger E.P., Krause P.J., Martone W.J., McGowan J.E., et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis 1994, 18(3):421.
21. Mackowiak P.A. Clinical thermometric measurements. Fever: basic mechanisms and management 1997, 27-34. Raven Press, New York. 2nd ed. P. Mackowiak (Ed.).
22. Haupt M.T., Jastremski M.S., Clemmer T.P., Metz C.A., Goris G.B. Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 1991, 19:1339-1347.
23. Badjatia N., Strongilis E., Gordon E., Prescutti M., Fernandez L., Fernandez A., et al. Metabolic impact of shivering during therapeutic temperature modulation: the Bedside Shivering Assessment Scale. Stroke 2008, 39:3242-3247.
24. Horvath S., Spurr G., Hutt B., Hamilton L. Metabolic cost of shivering. J Appl Physiol 1956, 8:595-602.
25. Doufas A.G., Lin C.M., Suleman M.I., Liem E.B., Lenhardt R., Morioka N., et al. Dexmedetomidine and meperidine additively reduce the shivering threshold in humans. Stroke 2003, 34(5):1218-1223.
26. Hata J.S., Shelsky C.R., Hindman B.J., Smith T.C., Simmons J.S., Todd M.M. A prospective, observational clinical trial of fever reduction to reduce systemic oxygen consumption in the setting of acute brain injury. Neurocrit Care 2007.
27. Kizilirmak S., Karakas S.E., Akca O., Ozkan T., Yavru A., Pembeci K., et al. Magnesium sulfate stops postanesthetic shivering. Ann N Y Acad Sci 1997, 813:799-806.
28. Kurz A., Ikeda T., Sessler D.I., Larson M.D., Bjorksten A.R., Dechert M., et al. Meperidine decreases the shivering threshold twice as much as the vasoconstriction threshold. Anesthesiology 1997, 86(5):1046-1054.
29. Wadhwa A., Sengupta P., Durrani J., Akca O., Lenhardt R., Sessler D.I., et al. Magnesium sulphate only slightly reduces the shivering threshold in humans. Br J Anaesth 2005, 94(6):756-762.
30. Lane J.E., Belson M.G., Brown D.K., Scheetz A. Chronic acetaminophen toxicity: a case report and review of the literature. J Emerg Med 2002, 23:253-256.
31. Bolesta S., Haber S.L. Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors. Ann Pharmacother 2002, 36:31-33.
32. Luo M., Fernandez-Estivariz C., Jones D.P., Accardi C.R., Alteheld B., Bazargan N., et al. Depletion of plasma antioxidants in surgical intensive care unit patients requiring parenteral feeding: effects of parenteral nutrition with or without alanyl-glutamine dipeptide supplementation. Nutrition 2008, 24:37-44.